Seeking Alpha

Venaxis (APPY -9.6%) slips today, despite its announcement late yesterday that European...

Venaxis (APPY -9.6%) slips today, despite its announcement late yesterday that European regulators have approved the company's blood-based appendicitis test APPY1. Initial sales are slated to begin during Q1 in key territories, including the UK, Italy, France, Germany and Benelux countries. The company expects to announce agreements with top EU distributors beginning in the first quarter 2013.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)